Medical 21 develops and manufactures artificial graft for coronary bypass surgery to eliminate the "harvesting" of vessels for cardiac bypass surgery - improving the quality of life for patients, and reducing costs for the healthcare system. There are over 800,000 heart bypass surgeries performed annually. For each of those surgeries, the surgical team needs to perform a second procedure, either on the patient's legs or arms, to harvest vessels that will be used for the bypasses.That second surgery can result in pain, additional scarring, and other complications for the patient.  If there is an infection, it can lead to an exponential increase in cost. An artificial bypass graft will eliminate the need for this second surgery, making it easier for patients and less expensive for the healthcare system.

Medical 21, Inc. is a developmental stage medical device company founded by Dr. Manny Villafaña and located in Minneapolis, MN.  We are developing and intend to commercialize and market an artificial graft to bypass blockages in the heart.